Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet

Pediatric Transplantation

Volumn 13, Issue 7, 2009, Pages 919-922

  Hubacek, Petr ^a   Keslova, Petra ^a   Formankova, Renata ^a   Pochop, Pavel ^a   Cinek, Ondrej ^a   Zajac, Miroslav ^a   Lochmanova, Jana ^b   Stary, Jan ^a   Sedlacek, Petr ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Cidofovir; Cytomegalovirus; Foscarnet; Ganciclovir resistance; Transplantation

Indexed keywords

BUSULFAN; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; PROBENECID; THYMOCYTE ANTIBODY; VIRUS DNA;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; IMMUNOTHERAPY; INFECTIOUS COMPLICATION; NEPHROTOXICITY; RETINITIS; TREATMENT OUTCOME; VIRUS ENCEPHALITIS; VIRUS REACTIVATION;

ADOLESCENT; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; CYTOSINE; ENCEPHALITIS, VIRAL; FEMALE; FOSCARNET; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; PHOSPHONIC ACIDS; RETINITIS; TREATMENT OUTCOME;

EID: 70349948970     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01070.x     Document Type: Article

References (7)

1. McGavin JK, Goa KL. Ganciclovir: An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 2001 : 61 : 1153 1183.
2. Battiwalla M, Wu Y, Bajwa RP, et al. Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis. Biol Blood Marrow Transplant 2007 : 13 : 765 770.
3. Wagstaff AJ, Bryson HM. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. Drugs 1994 : 48 : 199 226.
4. Chrisp P, Clissold SP. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 1991 : 41 : 104 129.
5. Cesaro S, Zhou X, Manzardo C, et al. Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation. J Clin Virol 2005 : 34 : 129 132.
6. Chou S, Erice A, Jordan MC, et al. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis 1995 : 171 : 576 583.
7. Narimatsu H, Kami M, Kato D, et al. Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Transpl Infect Dis 2007 : 9 : 11 15.